Address
Email address
Phone number
https://cellintechnologies.comCell Therapy Company | Cellin TechnologiesContract GMP manufacturing services for aseptically prepared cell therapy medicinal products.
Name
OÜ Cellin Technologies
Registry code
11543666
VAT number
EE101262352
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
30.09.2008 (17)
Financial year
01.01-31.12
Capital
321 758.00 €
Activity
72101 -
4 028 €
-646 665 €
-16054%
2 494 €
(estimate is approximate)
5 249 594 €
6
Submitted
No tax arrears
-12%
-9%
| Owner | Representative | Beneficial owner | |
|---|---|---|---|
| Ivari Saar
| - | Board member | Member of a higher management body, i.e. board member or supervisory board member |
| M.K.K Investeeringute OÜ 11814817 | 2% - 7 702.00 EUR | - | - |
| aktsiaselts INFO-AUTO 10078598 | 20% - 64 360.00 EUR | - | - |
| Globalex Europe OÜ 11712175 | 0% - 595.00 EUR | - | - |
| OÜ Raik ja Pojad 10677436 | 2% - 5 281.00 EUR | - | - |
| OÜ Syndoc 14108675 | 2% - 4 916.00 EUR | - | - |
| OÜ Postinvest 14241090 | 12% - 38 839.00 EUR | - | - |
| OÜ Kesaten Invest 10890584 | 9% - 28 969.00 EUR | - | - |
| Hollin Invest OÜ 11327218 | 6% - 19 262.00 EUR | - | - |
| Teddy Invest OÜ 14281617 | 0% - 1 500.00 EUR | - | - |
| AS Taastava Kirurgia Kliinik 10286204 | 43% - 137 619.00 EUR | - | - |
| KATAMER OÜ 10907729 | 4% - 12 590.00 EUR | - | - |
| Anu Aaspõllu
| 0% - 125.00 EUR | - | - |
| Owner | Representative | Beneficial owner | |
|---|---|---|---|
| Biolaborid OÜ 11879691 | 72% - 82 511.00 EUR | - | - |
| 2019 02.11.2020 | 2020 01.07.2021 | 2021 04.08.2022 | 2022 02.08.2023 | 2023 12.08.2024 | 2024 01.10.2025 | |
|---|---|---|---|---|---|---|
| Total Revenue | 8 040 € | 16 580 € | 10 015 € | 17 424 € | 2 448 € | 4 028 € |
| Net profit (loss) for the period | -476 459 € | -845 808 € | -636 798 € | -613 024 € | -370 953 € | -646 665 € |
| Profit Margin | -5926% | -5101% | -6358% | -3518% | -15153% | -16054% |
| Current Assets | 429 700 € | 15 920 € | 15 175 € | 113 609 € | 171 133 € | 27 375 € |
| Fixed Assets | 1 356 743 € | 8 183 434 € | 7 844 689 € | 7 509 452 € | 7 145 993 € | 6 820 671 € |
| Total Assets | 1 786 443 € | 8 199 354 € | 7 859 864 € | 7 623 061 € | 7 317 126 € | 6 848 046 € |
| Current Liabilities | 1 692 264 € | 2 045 460 € | 2 394 768 € | 2 012 679 € | 1 376 684 € | 1 333 452 € |
| Non Current Liabilities | 74 152 € | 133 152 € | 141 152 € | 141 152 € | 44 152 € | 265 000 € |
| Total Liabilities | 1 766 416 € | 2 178 612 € | 2 535 920 € | 2 153 831 € | 1 420 836 € | 1 598 452 € |
| Share Capital | - | - | - | - | - | - |
| Equity | 20 027 € | 6 020 742 € | 5 323 944 € | 5 469 230 € | 5 896 290 € | 5 249 594 € |
| Employees | 3 | 3 | 3 | 5 | 6 | 6 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2025 Q4 | 3 872 € | 24 003 € | 25 904 € | 7 |
| 2025 Q3 | 4 044 € | 21 542 € | 22 887 € | 7 |
| 2025 Q2 | 1 728 € | 13 994 € | 15 823 € | 7 |
| 2025 Q1 | 47 235 € | 14 502 € | 16 084 € | 7 |
| 2024 Q4 | 9 802 € | 20 667 € | 22 013 € | 7 |
| 2024 Q3 | 5 369 € | 21 395 € | 22 788 € | 7 |
| 2024 Q2 | 700 € | 22 248 € | 21 399 € | 7 |
| 2024 Q1 | 624 € | 18 905 € | 20 126 € | 7 |
| 2023 Q4 | 28 160 € | 20 125 € | 21 368 € | 6 |
| 2023 Q3 | 11 391 € | 20 339 € | 21 559 € | 6 |
| 2023 Q2 | 10 140 € | 18 056 € | 19 168 € | 6 |
| 2023 Q1 | 788 € | 20 173 € | 21 362 € | 6 |
| 2022 Q4 | 15 600 € | 18 564 € | 19 749 € | 7 |
| 2022 Q3 | 20 358 € | 20 034 € | 21 376 € | 7 |
| 2022 Q2 | 700 € | 12 971 € | 13 675 € | 9 |
| 2022 Q1 | 2 186 € | 8 345 € | 8 666 € | 10 |
